Patents by Inventor Evelyne GICQUEL-ZOUIDA

Evelyne GICQUEL-ZOUIDA has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • NOVEL POLYNUCLEOTIDES ENCODING A HUMAN FKRP PROTEIN
    Publication number: 20230321277
    Abstract: The present invention concerns synthetic polynucleotides encoding a human fukutin-related protein (FKRP) wherein the synthetic polynucleotides contain at least a mutation avoiding supplementary transcript(s) generated from frameshift start codon(s). The synthetic polynucleotides are useful, especially for treating a pathology linked to a FKRP deficiency or induced by a defect in ?-dystroglycan (?-DG) glycosylation, such as LGMD2I.
    Type: Application
    Filed: March 2, 2023
    Publication date: October 12, 2023
    Inventors: Isabelle RICHARD, Evelyne GICQUEL-ZOUIDA, William LOSTAL
  • Synthetic polynucleotides encoding a human FKRP protein
    Patent number: 11596698
    Abstract: The present invention concerns synthetic polynucleotides encoding a human fukutin-related protein (FKRP) wherein the synthetic polynucleotides contain at least a mutation avoiding supplementary transcript(s) generated from frameshift start codon(s). The synthetic polynucleotides are useful, especially for treating a pathology linked to a FKRP deficiency or induced by a defect in ?-dystroglycan (?-DG) glycosylation, such as LGMD2I.
    Type: Grant
    Filed: July 6, 2018
    Date of Patent: March 7, 2023
    Assignees: GENETHON, UNIVERSITE D'EVRY-VAL-D'ESSONNE, INSERM (INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE)
    Inventors: Isabelle Richard, Evelyne Gicquel-Zouida, William Lostal
  • NOVEL POLYNUCLEOTIDES ENCODING A HUMAN FKRP PROTEIN
    Publication number: 20210338837
    Abstract: The present invention concerns synthetic polynucleotides encoding a human fukutin-related protein (FKRP) wherein said polynucleotides contain at least a mutation avoiding supplementary transcript(s) generated from frameshift start codon(s). Said polynucleotides are useful, especially for treating a pathology linked to a FKRP deficiency or induced by a defect in ?-dystroglycan (?-DG) glycosylation, such as LGMD2I.
    Type: Application
    Filed: July 6, 2018
    Publication date: November 4, 2021
    Inventors: Isabelle RICHARD, Evelyne GICQUEL-ZOUIDA